Cargando…
Effects of lacosamide and carbamazepine on lipids in a randomized trial
OBJECTIVE: The effects of anticonvulsants on lipids are the subject of considerable concern and investigation, but there are almost no data on this issue from randomized trials. We evaluated serum lipid profiles in adults with newly diagnosed epilepsy, following randomization to lacosamide (LCM) or...
Autores principales: | Mintzer, Scott, Dimova, Svetlana, Zhang, Ying, Steiniger‐Brach, Björn, De Backer, Marc, Chellun, Daya, Roebling, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756649/ https://www.ncbi.nlm.nih.gov/pubmed/33200428 http://dx.doi.org/10.1111/epi.16745 |
Ejemplares similares
-
Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy
por: Ben‐Menachem, Elinor, et al.
Publicado: (2019) -
Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
por: Bainbridge, Jacquelyn, et al.
Publicado: (2017) -
Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial
por: Ben‐Menachem, Elinor, et al.
Publicado: (2021) -
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
por: Vossler, David G, et al.
Publicado: (2020) -
Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
por: Reinhardt, Fritjof, et al.
Publicado: (2019)